1. Patient survival/death: Refers to whether the patient survived following the transplantation or not.

  2. Graft survival: Relates to the success of the transplanted organ. Death-censored refers to the survival of the graft without considering the death of the patient as a failure, while all-cause includes all reasons.

  3. DGF (Delayed Graft Function): A complication where the kidney doesn’t function immediately after transplantation.

  4. PNF (Primary Non-Function): When the transplanted kidney never functions.

  5. Acute rejection: The body’s immediate reaction to recognizing the kidney as foreign.

  6. Racial category: The race of the patient, which may be considered in studies examining disparities in transplant outcomes.

  7. PRA (Panel Reactive Antibody), Time-varying PRA: Measures how likely a patient will react against different human leukocyte antigens (HLA).

  8. Kidney disease etiology/diagnosis: The underlying cause or diagnosis of the kidney disease.

  9. Fix ABO/ABO mismatch: Blood type matching and compatibility between donor and recipient.

  10. Age at transplant in years.

  11. BMI: Body Mass Index, a measure of body fat.

  12. CIT (Cold Ischemia Time): The time the organ is kept on ice before transplantation.

  13. Donor DM, HTN, terminal SCr > 1.5, ECD, SCr Assessment: Characteristics of the donor, such as diabetes mellitus, hypertension, terminal serum creatinine, and extended criteria donor classification.

  14. HLA mismatch: Differences in human leukocyte antigens between donor and recipient.

  15. Duration of pre-KT dialysis: The time on dialysis before kidney transplantation.

  16. HCV: Hepatitis C virus, considered for candidate, recipient, and donor.

  17. HCC: Hepatocellular carcinoma, a type of liver cancer.

  18. Immunosuppression/Induction: Medications to prevent organ rejection.

  19. Insurance: Coverage for the transplantation procedure.

  20. KDRI/KDPI, DRI, EPTS: Various scores and indices to evaluate the quality and suitability of a donor organ.

  21. Machine perfusion: A method to preserve organs outside the body.

  22. MELD: Model for End-Stage Liver Disease score, used to prioritize liver transplant candidates.

  23. Previous solid organ Tx/previous KT: History of prior organ transplants or kidney transplants.

  24. Organ Sharing: Policies governing how organs are allocated.

  25. De-identification Code: A code to anonymize patient information.

  26. Transplant Date: The date when the transplant was performed.

  27. LDPKI: Living Donor Profile Index, a measure used to assess the quality of living kidney donors.

These terms encompass a complex and multifaceted procedure, reflecting the many variables and factors that can affect the outcomes of a kidney transplant.

Some additional notes on the data can be found here